Company Filing History:
Years Active: 2017
Title: Xueli Zhang: Innovator in Alzheimer's Disease Research
Introduction
Xueli Zhang is a notable inventor based in Malden, MA (US). He has made significant contributions to the field of Alzheimer's disease research through his innovative work on curcumin analogs. His research focuses on developing compounds that can potentially aid in the treatment of this debilitating condition.
Latest Patents
Xueli Zhang holds a patent for curcumin analogs, which are designed to interact with amyloid β (Aβ) and reduce the copper-induced crosslinking of Aβ. This innovative approach may provide new avenues for treating Alzheimer's disease or related disorders. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Zhang is affiliated with The General Hospital Corporation, where he continues to pursue his research interests. His work is characterized by a dedication to finding effective treatments for Alzheimer's disease, which affects millions of individuals worldwide.
Collaborations
Xueli Zhang collaborates with esteemed colleagues, including Chongzhao Ran and Anna V. Moore, who contribute to his research efforts. Their combined expertise enhances the potential impact of their work in the field of Alzheimer's research.
Conclusion
Xueli Zhang's innovative research on curcumin analogs represents a promising step forward in the fight against Alzheimer's disease. His contributions to this critical area of study highlight the importance of continued innovation in medical research.